The market is undergoing notable growth, principally boosted by escalating incidents of type 2 diabetes across the globe and heightening need for effective glucose-lowering drugs
Ipamorelin is a growth hormonereleasing peptide that is sometimes used in clinical wellness settings under medical supervision
Two companies Novo Nordisk and Eli Lilly reported a combined USD 45.7 billion in audited GLP-1 revenue in 2024 alone, from just two active ingredients
Treatment of Primary Carnitine Deficiency Treatment of primary carnitine deficiency patients with dietary carnitine supplementation (100400 mg/kg/day) has been shown to be highly beneficial, particularly if started before irreversible organ damage occurs
Glucagon is a hormone that signals the liver to release stored energy, and in animal studies has been shown to stimulate thermogenesis (heat production) in fat tissue, but this effect has not been clearly confirmed in humans
Gastrointestinal Effects: GLP-1 slows down gastric emptying and changes intestinal motility, leading to symptoms like nausea, vomiting, diarrhea, and constipation